160 related articles for article (PubMed ID: 28002655)
1. Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation.
Egawa H; Umeshita K; Uemoto S
J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):89-94. PubMed ID: 28002655
[TBL] [Abstract][Full Text] [Related]
2. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
[TBL] [Abstract][Full Text] [Related]
3. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
Kim SH; Lee EC; Shim JR; Park SJ
Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
[TBL] [Abstract][Full Text] [Related]
4. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
5. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.
Egawa H; Teramukai S; Haga H; Tanabe M; Mori A; Ikegami T; Kawagishi N; Ohdan H; Kasahara M; Umeshita K
Am J Transplant; 2014 Jan; 14(1):102-14. PubMed ID: 24279828
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
[TBL] [Abstract][Full Text] [Related]
7. Present status of ABO-incompatible living donor liver transplantation in Japan.
Egawa H; Teramukai S; Haga H; Tanabe M; Fukushima M; Shimazu M
Hepatology; 2008 Jan; 47(1):143-52. PubMed ID: 17929298
[TBL] [Abstract][Full Text] [Related]
8. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
Kim JD; Choi DL; Kim SG; Lee AJ
Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
[TBL] [Abstract][Full Text] [Related]
9. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
Lee EC; Kim SH; Shim JR; Park SJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation.
Yamamoto H; Uchida K; Kawabata S; Isono K; Miura K; Hayashida S; Oya Y; Sugawara Y; Inomata Y
Transplantation; 2018 Jan; 102(1):97-104. PubMed ID: 28938311
[TBL] [Abstract][Full Text] [Related]
11. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
12. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
[TBL] [Abstract][Full Text] [Related]
13. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
[TBL] [Abstract][Full Text] [Related]
14. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: the experience of a single center.
Okada N; Sanada Y; Hirata Y; Yamada N; Wakiya T; Ihara Y; Urahashi T; Miki A; Kaneda Y; Sasanuma H; Fujiwara T; Sakuma Y; Shimizu A; Hyodo M; Yasuda Y; Mizuta K
Pediatr Transplant; 2015 May; 19(3):279-86. PubMed ID: 25689881
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
16. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis.
Jun IG; Lee B; Kim SO; Shin WJ; Bang JY; Song JG; Song GW; Lee SG; Hwang GS
Liver Transpl; 2016 Dec; 22(12):1656-1665. PubMed ID: 27595780
[TBL] [Abstract][Full Text] [Related]
17. Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India.
Shajahan S; Sasidharan ST; Surendran S; Shenoy V; Padma UD
Indian J Gastroenterol; 2019 Feb; 38(1):23-28. PubMed ID: 30848450
[TBL] [Abstract][Full Text] [Related]
18. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
[TBL] [Abstract][Full Text] [Related]
19. Adult living-donor liver transplantation with ABO-incompatible grafts.
Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
[TBL] [Abstract][Full Text] [Related]
20. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
